DYMDF:OTCMKTS
Diamyd Medical AB
$0.73
0.00%
(0.00) 1D
Apr 14, 2:48:13 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DYMDF...
Mkt. cap
148.00M
Volume
0.00
52-wk high
$0.73
52-wk low
$0.73
Shares outstanding
134.00M
No. of employees
42
Mkt. cap
148.00M
Volume
0.00
52-wk high
$0.73
52-wk low
$0.73
Shares outstanding
134.00M
No. of employees
42
News stories
From web sources and news partners
upi
·
43 minutes ago
Nasdaq tech stocks recover but Wall Street posts 4th weekly loss
RealMoney Pro
·
19 minutes ago
Tech Bounces, but the S&P 500 Still Has Its Worst Week Since April 2025
www.tokenpost.com
·
1 hour ago
Tech’s 37% S&P 500 Weight Raises Risk From AI Stock Rotation
www.tmgm.com
·
2 hours ago
United States CFTC S&P 500 NC Net Positions up to $-129.4K from previous $-134.4K
Profile
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for type-1 diabetes. The company's investigational drug retogatein is based on a recombinant form of GAD₆₅, one of two human glutamate decarboxylase gene products.
The company is headquartered in Stockholm, and maintains a "biomanufacturing" facility in Umeå which utilizes bacuolavirus-mediated protein expression. Wikipedia
About Diamyd Medical AB
CEOUlf Hannelius
Employees42
Founded1984
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitediamyd.com